UBS Initiates Jasper Therapeutics(JSPR.US) With Buy Rating, Announces Target Price $38

Moomoo NewsFeb 13 12:32 ET · Ratings

Jasper Therapeutics (JSPR) Gets a Buy From UBS

TipRanksFeb 13 10:18 ET · Ratings

UBS Initiates Coverage On Jasper Therapeutics With Buy Rating, Announces Price Target of $38

BenzingaFeb 13 09:20 ET · Ratings

Jasper Therapeutics To Present On Briquilimab At American Academy Of Allergy, Asthma, And Immunology Annual Meeting

BenzingaFeb 10 08:03 ET

Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Jasper TherapeuticsFeb 10 00:00 ET

Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference

Jasper TherapeuticsFeb 4 00:00 ET